Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03576417
Title A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck (NIVOPOSTOP)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Groupe Oncologie Radiotherapie Tete et Cou

laryngeal squamous cell carcinoma

oropharynx cancer

hypopharynx cancer

head and neck squamous cell carcinoma

oral squamous cell carcinoma



Cisplatin + Nivolumab

Age Groups: adult | senior
Covered Countries FRA

Additional content available in CKB BOOST